This site is intended for healthcare professionals

CPD
CPD
Pro
Pro
Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Drug interactions

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Sulphonylureas are subject to a number of interactions although these are rarely important clinically. There hypoglycaemic effects can be altered by:

  • pharmacodynamic interactions with:
    • glucocorticoids
    • beta-blockers

  • pharmacokinetic interactions by 3 mechanisms:
    • reduction in renal elimination for example by allopurinol
    • reduction or acceleration of hepatic metabolism by cimetidine, or carbamazepine and phenytoin, respectively
    • displacement from protein binding sites - sulphonylureas are up to 99% protein bound - for example by salicylates

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.